Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christelle Vincent-Fabert

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|June 11, 2021
Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell LymphomasQuentin Lemasson, Hussein Akil, Jean Feuillard, et al.
Frontiers in Immunology|October 8, 2024
Editorial: Community series in mouse models of B cell malignancies, volume IIGema Perez-Chacon, Christelle Vincent-Fabert, Juan M Zapata
Frontiers in Immunology|November 15, 2021
Editorial: Mouse Models of B Cell MalignanciesGema Perez-Chacon, Christelle Vincent-Fabert, Juan M Zapata
Oncotarget|October 13, 2016
The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
European Journal of Immunology|November 17, 2010
The IgH 3' regulatory region and its implication in lymphomagenesisChristelle Vincent-Fabert, Rémi Fiancette, Michel Cogné, et al.
Cell Communication and Signaling : CCS|August 7, 2019
Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphomaChristelle Vincent-Fabert, Lilian Roland, Ursula Zimber-Strobl, et al.
The Journal of Biological Chemistry|January 25, 2012
Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombinationPauline Rouaud, Christelle Vincent-Fabert, Remi Fiancette, et al.
Leukemia Research|June 16, 2009
Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgeneChristelle Vincent-Fabert, Rémi Fiancette, Véronique Truffinet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3' IgH regulatory regionChristelle Vincent-Fabert, Véronique Truffinet, Remi Fiancette, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|June 11, 2021
Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell LymphomasQuentin Lemasson, Hussein Akil, Jean Feuillard, et al.
Frontiers in Immunology|October 8, 2024
Editorial: Community series in mouse models of B cell malignancies, volume IIGema Perez-Chacon, Christelle Vincent-Fabert, Juan M Zapata
Frontiers in Immunology|November 15, 2021
Editorial: Mouse Models of B Cell MalignanciesGema Perez-Chacon, Christelle Vincent-Fabert, Juan M Zapata
Oncotarget|October 13, 2016
The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
European Journal of Immunology|November 17, 2010
The IgH 3' regulatory region and its implication in lymphomagenesisChristelle Vincent-Fabert, Rémi Fiancette, Michel Cogné, et al.
Cell Communication and Signaling : CCS|August 7, 2019
Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphomaChristelle Vincent-Fabert, Lilian Roland, Ursula Zimber-Strobl, et al.
The Journal of Biological Chemistry|January 25, 2012
Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombinationPauline Rouaud, Christelle Vincent-Fabert, Remi Fiancette, et al.
Leukemia Research|June 16, 2009
Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgeneChristelle Vincent-Fabert, Rémi Fiancette, Véronique Truffinet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3' IgH regulatory regionChristelle Vincent-Fabert, Véronique Truffinet, Remi Fiancette, et al.
Pageof 3